The document provides an agenda for press events at the AUA PRESS PROGRAM occurring from May 14-17, 2011. It lists the date, time, title, abstract numbers, and moderator for various panel discussions and presentations covering topics in urology including public health issues, erectile dysfunction, prostate cancer, kidney cancer, prostate-specific antigen testing, pediatric urology, smoking impacts, and treatments for conditions like interstitial cystitis. Conference call access is provided for members of the press to participate in question and answer sessions after each event.
1. AUA PRESS PROGRAM EVENTS
Note: All abstracts are under embargo until date and time of presentation, or until featured in a press
conference (whichever is earlier).
Conference calls will be available for each press event. To access the call, please dial 1-877-544-1231
and use conference code 1959356184.
Saturday, May 14, 2011
12:30 p.m.: PANEL: PUBLIC HEALTH ISSUES IN UROLOGY
(Abstracts 50, 81, 314 1251)
Moderator: Tomas L. Griebling, MD, MPH
2:00 p.m.: PANEL: SLEEP AND ERECTILE DYSFUNCTION
(Abstracts 57, 1325)
Moderator: Kevin T. McVary, MD
Sunday, May 15, 2011
10:00 a.m.: PANEL: SMOKING AND UROLOGIC DISEASE
(Abstracts 1065, 1256)
Moderator: Tobias Kohler, MD
11:00 a.m.: GAY MEN WITH PROSTATE CANCER REPORT SIGNIFICANTLY WORSE HEALTH-RELATED
QUALITY OF LIFE THAN HETEROSEXUAL MEN
(Abstract 163)
Moderator: Tomas L. Griebling, MD, MPH
11:30 a.m.: AGENT ORANGE AND KIDNEY CANCER
(Abstract 529)
Moderator: Anthony Y. Smith, MD
2:00 p.m.: PANEL: MANAGEMENT OF SMALL RENAL MASSES
(Abstracts 66, 540, 1663, 1668)
Moderator: Anthony Y. Smith, MD
Monday, May 16, 2011
8:00 a.m.: RE-EPITHELIZATION OF A DEMUCOSALIZED STOMACH PATCH WITH UROTHELIAL CELL
SEEDED SMALL INTESTINE SUBMUCOSA
(Abstract 1512)
Moderator: Anthony Atala, MD
2. 9:00 a.m.: PANEL: REVISITING AND REFINING THE PROSTATE-SPECIFIC ANTIGEN TEST
(Abstracts 986, 1197, 2025, 2032)
Moderator: Christopher A. Amling, MD
10:00 a.m.: ABIRATERONE ACETATE PLUS LOW-DOSE PREDNISONE IN METASTATIC, CASTRATION-
RESISTANT PROSTATE CANCER AFTER DOCETAXEL-BASED CHEMOTHERAPY
(Abstract 705)
Moderator: Christopher A. Amling, MD
11:00 a.m.: PANEL: ADVANCES IN PEDIATRIC UROLOGY
(Abstracts 456, 827, 1382)
Moderator: Anthony Atala, MD
1:00 p.m.: PANEL: NEW GENETICS AND BIOMARKERS TO IDENTIFY UROLOGIC DISEASE
(Abstracts 715, 1362, 1616, 2289, 2319, 2325)
Moderator: Anthony Y. Smith, MD
2:00 p.m.: PANEL: MANAGEMENT OF LOW-VOLUME, LOW-RISK PROSTATE TUMORS
(Abstracts 187, 1292, 2127)
Moderator: Joseph C. Presti, MD
3:00 p.m.: SMOKING AND ADVERSE OUTCOMES AT RADICAL PROSTATECTOMY
(Abstract 459)
Data presented by Joseph C. Presti, MD
Tuesday, May 17, 2011
8:00 a.m.: PANEL: IMPACT OF LIFESTYLE ON STONE DISEASE
(Abstracts 2139, 2146, 2233, 2239)
Moderated by Dean G. Assimos, MD
10:00 a.m.: PANEL: INNOVATIVE TREATMENT FOR INTERSTITIAL CYSTITIS AND CHRONIC PELVIC
PAIN SYNDROMES
(Abstracts 810, 950, 1431, 1433, 1511)
Moderator: Tomas Griebling, MD, MPH
11:00 a.m.: HOSPITAL DISCHARGE TRENDS FOR BPH, 1998-2007
(Abstract 1721)
Moderator: Kevin T. McVary, MD
11:30 a.m.: PREVALENCE OF HPV INFECTION OF THE INNER FORESKIN IN MEN WITHOUT CLINICAL
SYMPTOMS
(Abstract 1423)
Moderated by Kevin T. McVary, MD